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1GENERAL INTRODUCTION
Post weaning diarrhea (PWD) caused by enterotoxigenic Escherichia coli (ETEC) is a
threat to the US swine industry due to losses in production associated with the disease.
Early weaned piglets are especially susceptible to disease threats because of an immature
immune system, a change in intestinal environment due to the diet transition from the
sow's milk to a grain based diet, and exposure to new pathogens in a group housed
environment. Colicins represent an alternative to the antibiotics now given in a majority
of post-weaning pig diets to combat infections, including PWD. Colicins are proteins
produced by E. coli that kill E. coli and other related bacterial species. We used a highly
purified Colicin E1 at 16.5 mg/kg in a five-day study or 20 mg/kg in a two week study to
successfully prevent PWD in piglets. In addition to the purified Colicin E1 from the
native producing E. coli strain we have also expressed the Colicin E1 in Pichia pastoris
yeast. This technique allows the Colicin E1 to be used as a directly fed antimicrobial that
would require no additional purification costs associated with the native strain.
2DISSERTATION ORGANIZATION
This dissertation is organized into three chapters. The first chapter is the proof of concept
trial which tested two different levels of Colicin E1 inclusion in the diet versus two
different ETEC challenge strains. The second chapter is a longer duration trial using a
slightly higher level of Colicin E1 in the diet against a seeder pig or natural infection
model. In this second trial the Colicin E1 additive was provided in the diet for two
weeks, then taken out of the diet for the second two week period to investigate the impact
of the diet change on growth and resistance to infection. The third chapter is the
expression and characterization of Colicin E1 in recombinant Pichia pastoris yeast.
The corresponding author on all research publications is Dr. Chad H. Stahl and Sara
Cutler is the primary author. Dr. Steven Lonergan performed all of the protein
purification of the Colicin E1. Dr. Anna Butters-Johnson provided animal behavior
analysis. Dr. Nancy Cornick provided the ETEC challenge strains as well as input on
challenge models for post-weaning diarrhea.
Chapter 1 has been submitted for publication to Antimicrobial Agents and Chemotherapy
and is under revision. Chapter 2 is being prepared for submission to the Journal of
Animal Science and Chapter 3 is being prepared for submission to Biotechnology Letters.
3LITERATURE REVIEW
Introduction
Post-weaning diarrhea (PWD) in pigs is a multifactorial disease resulting from
changes in housing environment after weaning, viral exposure, immune system
immaturity, and a transition from a liquid to a solid diet that leaves a vulnerable intestinal
environment. Piglets that are weaned at two weeks of age are immunocompromised due
to a loss of antibodies in the sow's milk. As a result of this disease threat, prophylactic
antibiotics are provided in the post-weaning diet in an effort to combat respiratory and
enteric infections. The intestinal environment of the recently weaned pig is particularly
susceptible to infection because of new disease threats in a new housing environment and
a switch from a milk based diet to one based on grain and protein. Enterotoxigenic
Escherichia coli (ETEC) are a major cause of opportunistic enteric infections in pigs, in
part thought to be due to this diet transition, but also because of rotavirus exposure that
further serves to disrupt the intestinal tract of the pig. ETEC-caused PWD in pigs causes
production losses due to higher feed to gain ratios and morbidity during the infection, by
leaving the animals vulnerable to other pathogens, and by creating a non-uniform set of
animals.
Enterotoxigenic Escherichia coli
In swine production ETEC-caused PWD is primarily a disease of just-farrowed neonatal
piglets or piglets that have been recently weaned. Enterotoxigenic E. coli have multiple
traits that are responsible for their virulence and variation in these virulence factors is
seen between different strains. The first trait necessary for ETEC to cause PWD is its
4ability to attach to the intestinal lining. Bacterial fimbriae mediate the attachment of the
ETEC to the intestinal cell. There are two main fimbrial types of E. coli associated with
PWD in piglets. Frydendahl, et al., reported in 2002 that 92.7% of PWD cases were
caused by F4 or F18 and more recently, Zhang, et al. (2007) reported that of the 58% of
the suspected ETEC isolates, from cases of PWD submitted for diagnostic evaluation,
were PCR positive for fimbriae and of those bacterial isolates 98.9% were F4 or F18.
There are three different genetically distinct antigenic variants of E. coli F4 fimbriae-
F4ab, F4ac, and F4ad and three intestinal receptor phenotypes represented in the swine
population (Jin and Zhao, 2000). The intestinal receptors are either glycolipid (ad) or
glycoprotein (ab, ac) in structure and they are located on the mucus or the brush border in
the intestine, respectively (Jin and Zhou, 2000). Receptors F4ab and F4ac are
predominantly found in the jejunum, while F4ad is located in the ileum (Jin and Zhao,
2000).
Escherichia coli encode two different F18 subtypes, F18ab and F18ac. Less is known
about the intestinal receptor for F18 in swine. However, a polymorphism in the FUT1
gene has been associated with genetic resistance to F18+ E. coli (Meirjink et al., 2000).
The phenotypic expression of the F18 receptor has recently been associated with the H-2
histo-blood group antigens expressed on the epithelial cells lining the intestinal tract
(Coddens, et al., 2007).
Though the different fimbriae bind only to their corresponding receptor and the brush
border receptors (proteins) do not change with the pig’s age, receptors found in the
glycolipid or mucus layer of the intestine do change with age and diet (Jin and Zhou,
2000). This observation could further explain why newborn or weaned piglets are more
5susceptible to certain types of E. coli and why diet potentially has a major influence on
intestinal colonization by ETEC.
ETEC Pathogenesis
After using their fimbrial adhesins to bind to intestinal receptors, ETEC bacteria, unlike
some other intestinal pathogens, do not invade the host cells. Rather, the bacteria remain
attached to the enterocyte and when they reach high enough numbers (estimated at 1x109
CFU), the bacteria produce toxins that utilize the enterocyte’s cellular machinery to
generate their pathogenic effects (reviewed, Turner 2006). Enterotoxigenic E. coli may
produce one or more enterotoxins and the genes encoding these toxins are either located
on a plasmid (STa and STb) or on the bacteria’s chromosomes (LT). These toxins are
characterized as either heat stabile (ST) or heat labile (LT) based on their thermostability.
The ST toxins are not inactivated after heat treatment at 100º C for 5 minutes whereas the
LT toxin is completely inactivated by treatment at 60º C for 15 min (Fairbrother et al.,
2005). The heat stabile toxins (ST) all result in fluid loss from the enterocyte although
their modes of actions once in the enterocyte vary (Turner, 2006). STa activates
guanylate cyclase (GC) in the cell causing an increase of cyclic guanosine
monophosphate (cGMP), which results in a disruption of Na and Cl absorption and fluid
loss from the enterocyte (Turner, 2006). STb-associated fluid loss in the intestine is
thought to be result of prostaglandin secretion (Fairbrother et al., 2005; Gyles, 1992). In
addition, another toxin that has structural similarity to STa, EAST1, has been recently
associated with ETEC diarrhea in pigs (Fairbrother, et al., 2005; Turner et al., 2006).
EAST1 also binds to the GC-C enterocyte receptor and upregulates GC for the
production of diarrhea. STa and EAST differ in amino acid sequence and EAST1 has
6been associated with human pathogenic E. coli disease as well whereas the other ST
toxins are primarily associated with animal infections (Fairbrother, et al., 2005; Turner et
al., 2006).
Heat labile toxin is an A-B (or AB5) subunit toxin, consisting of an active or A domain
and a B or binding domain (Kaper, et al., 2004). The A domain of LT is a type II effector
that enters the host cell, and through Gs coupling, activates adenylate cyclase which
results in an increase in cyclic adenylate monophosphate (CAMP) and excessive Na,
bicarbonate, and Cl secretion, leading to dehydration and fluid loss in the animal (Gyles,
2007; Spangler, 1992). Shiga toxin (STx2e) is associated with edema disease in pigs and
also found in association with PWD infections (Fairbrother, et al., 2005). The STx2e
toxin (verotoxin) is also an AB subunit toxin but instead of Gs stimulation, STx inhibits
protein synthesis in the host, inducing apoptosis (Kaper, et al., 2004). In addition to these
toxins, alpha hemolysin has been associated with a majority (82%) of PWD strains when
initially isolated (Frydendahl, et al., 2002). The alpha hemolysin, a pore forming
cytolysin, can cause damage to host cells and is carried on a plasmid in swine pathogenic
ETEC. The alpha hemolysin has been associated with an increase in virulence in PWD
causing bacteria, though reports differ on its importance in pathogenesis (Chen, et.al,
2004; Smith and Lingood, 1971; Moxley et al., 1998). The lipopolysaccharide of the
ETEC strain recovered served to classify ETEC strains prior to virotyping. Typical O
(lipopolysaccharide) antigens in post-weaning diarrhea include O138, O139, O141, and
O149), though the specific types vary by region (Fairbrother, et al., 2005).
Experimental Challenge Models for ETEC
7One of the major challenges of investigating PWD is the development of a reliable,
reproducible challenge model that is representative of the disease seen in the field. The
use of different challenge strains with varying fimbrial antigens and toxins as well as
varying resistance to colonization among the study animals can result in enormous
variation among experimentally induced (ETEC caused) PWD studies. Because of these
complex factors involved in experimentally replicating PWD, comparing results from one
study to the next, let alone between research groups, is a major hindrance to ETEC
research. This has impaired the development of intervention strategies, other than
changes in management practices (Madec, et al., 2000). Optimizing the efficacy and
repeatability of ETEC challenge studies, would allow for dramatic advances in the
development of novel interventions for preventing PWD.
Very different challenge protocols have been used to examine PWD. These protocols
vary in bacterial load, inoculation frequency, and co-infection or environmental
sensitizers (Sarmiento, et al., 1988; Wathes, et al., 1989). The first critical step in a
successful infection model is ensuring that the challenge strain is delivered into the
intestinal tract in a viable state. Some studies have attempted to increase the amount of
their oral challenge strain that survives into the intestine by decreasing the acidity of the
stomach with the use of bicarbonate or calcium carbonate (Sarmiento et al., 1988; Madec,
et al., 2000; Girard, et al., 2005). Other methods to achieve this same goal include the
use of capsules (Tsukahara, et al., 2007) or gastric tubes (Sarmiento, et al., 1988; Girard,
et al., 2005). Tsukahara et al. (2007) successfully induced ETEC-caused edema disease
by orally administering one capsule containing 4x108 CFU of 0139(F18,STx2e) Shiga
toxin producing E. coli daily for three days. Sarmiento used 1x1010CFU of O157:K88ac;
8(H43, LT, STb) in a gastric tube with 1.2% sodium bicarbonate and was able to generate
clinical signs of disease. Girard, et al., used an intraoesophagic 1.2% calcium carbonate
infusion followed by 1x1010 CFU of ECL 1001 enteropathogenic E. coli (EPEC), and
was able to identify histopathologic changes in the intestine but no clinical signs
associated with challenge.
Inadvertently or intentionally exposing animals to transmissible gastroenteritis (TGE) or
Rota virus predisposes the challenged animals to ETEC infection (Melin and Wallgren,
2002; Benfield, et al., 1988; Cox, et al., 1988; Sarmiento et al., 1988; Geenen et al.,
2005). While a viral challenge can lower the resistance of the animal to an ETEC
infection (this is a likely scenario in the field), doing so adds a confounding effect in
studies examining interventions for ETEC caused PWD.
Other modes of bacterial challenge, such as inclusion of the bacteria in the feed or
exposure to a contaminated environment have also been used to induce PWD
(Frydendahl, et al., 2003; Melin and Wallgren, 2002). Frydendahl et al. (2003) used a
daily dose of 1x108 CFU O138(F18) in the feed and was to achieve diarrhea in 71.4% of
the challenged pigs. Repeated inoculation more closely mimics the natural route of fecal-
oral infection than does gastric tubing or delivering the bacteria in a capsule. Perhaps
more realistic than these methods is exposure to a contaminated environment. When
investigating different dietary interventions to prevent PWD, Melin and Wallgren (2002)
transported just-weaned piglets in a trailer coated with 2x106CFU/square meter of ETEC
strains 0147:K89,STb and three days after weaning exposed the piglets a second time
using the same method same way with different challenge strains [0141:K85(STb,VT2)
0149:K91(K88,STa, STb, LT)]. This challenge method resulted in diarrhea in 34/36
9exposed animals, regardless of whether they tested positive for the F4 receptor via a post
mortem adhesion assay (Melin and Wallgren, 2002).
It has been speculated that the diet the piglets are fed immediately after weaning may
have an effect on the occurrence of PWD as well. A post-weaning starter diet that
contains milk products is favored because it eases the transition to grain-based diet
(Fairbrother, 2005). However, a post weaning starter diet that contains soybean meal is
thought to exacerbate the potential for PWD. A transient inflammatory response to the
soy protein adds to the difficult transition from milk to solid feed (Li, et al., 1991; Dreau,
et al., 1994).
Combining both nutritional manipulations and ETEC challenge approaches, Madec, et al.
(2001) used an inoculum containing four different F4 (LT, STa, STb) ETEC at levels
ranging from 108 to 1012 CFU either once, daily, or at four day intervals. The route of
infection (oral or gastric tube), witholding of feed or water prior to inoculation, the use of
bicarbonate to reduce gastric acidity, or dietary change to a high protein diet did not seem
to influence the development of diarrhea in these pigs. The challenge dose did, however,
as did the presence of the F4 receptor (presumptively based on post mortem agglutination
testing). Ten out of the sixteen animals challenged at the highest level, 1x1012CFU, on
four challenge days, died. The pigs used in this study were specific pathogen free but
only 56% tested positive on the agglutination test for the F4 receptor. In the animals that
were the F4 ETEC adhesive type, 56.7% developed diarrhea while 34% of the non-
adhesive type showed clinical signs.
With any multifactorial disease, an experimental model that combines several
predisposing conditions will increase the chances of reproducing the disease. The
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absence of viral infection, the presence of the intestinal receptor for the challenge strain
used, and using a post weaning diet that provides adequate nutrition while increasing the
amount of crude protein may be the most practical approach to reproducing post-weaning
diarrhea in pigs experimentally. The determining factor in the development of PWD in
the pig when exposed to sufficient levels of ETEC to cause disease may be genetic
background and presence of the fimbrial receptor in the intestine.
Genetic Susceptibility
Despite all of the other factors which can affect the success of an ETEC challenge study
in young pigs, the most influential determinant in the development of F18 or F4 caused
PWD is the presence of receptors on the ileal or jejunal brush borders or mucosa of the
small intestine. Without the receptors for E. coli fimbrial adhesion, it is unlikely that
colonization will occur. These receptors are highly specific for distinct fimbria. The
genetic locus for the F18 receptor is separate from that of the F4 receptor, with the F18
receptor having been mapped to chromosome 6 and the F4 receptor mapped to
chromosome 13 (Meijerink, et al., 2000). Both are inherited in Mendelian fashion with
the lack of the F4 receptor being on the dominant allele and the lack of the F18 receptor
being recessive (Fairbrother, et al., 2005).
The F4 receptor has been the target of selective breeding programs and has been reduced
in some swine populations, while the F18 receptor has been mapped to a region of the
porcine chromosome near the region of the stress gene and is not of a selective advantage
to target this locus (Nagy, et al., 2005). In fact, increases in F18 associated PWD have
been noted after the reduction of the stress gene in some swine populations (Nagy, et al.,
2005). The DNA polymorphism for susceptibility to F18 colonization on the intestinal
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brush border is in the (1,2) fucosyltransferase gene (Meijerink, et al., 2000) and is
detectable by a PCR-RFLP as described by Frydendahl et al. (2003). By selecting test
animals that had a polymorphism at this site for susceptibility, the percentage of pigs that
developed diarrhea was increased from 5.9% to 71.4%. Although some genetically
resistant pigs did shed considerable numbers of the challenge strain and some of the
genetically susceptible pigs did not develop diarrhea, this is theoretically due to the
transient nature of the expression of the receptor itself. The pigs in this study were
challenged for 10 days with 1x108 CFU with the peak shedding occurring around day
five.
Prevention and Control of Post-Weaning Diarrhea
Prophylactic antibiotics are now given at most large swine facilities (92%) in part to
control PWD (USDA NAHMS, 2001). The use of antibiotics in swine feed for growth
promotion and/or disease prevention is common practice in the United States. Over 87%
of market pigs produced in the U.S. received prophylactic antibiotic treatments in their
feed or water (USDA NAHMS, 2001). Despite this practice, ETEC-associated PWD
infections still occur. Forty-three percent of large swine producers reported an
occurrence of PWD in 2001 (USDA NAHMS, 2001). Bacteria are isolated from the air
(Chapin, et al., 2005), water (Anderson and Sobsey, 2006) from pigs (Maynard, et al.,
2003; Mathew et al., 1999), and from people who work with the pigs (Campbell et al.,
2005) all indicate that a spread of antimicrobial resistant bacteria. In addition, E. coli
resistant to multiple antimicrobial compounds is on the rise over the past two decades
(Maynard, et al., 2003). Alternatives to these antibiotics for use in the animal feed is
important as removal of these compounds will add to production costs. The use of
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antibiotics in the grower-finisher diet is estimated to save the US producer $3/pig in net
return because of increases in efficiency (Cromwell, 2002). If antibiotics are banned
from the feed in the US it has been estimated that production costs will rise by $4.50/pig
(Hayes and Jensen, 2003).
Current Alternative Therapies
Alternatives to antibiotic supplementation in the swine diet include the use of high levels
of zinc oxide, pre- and probiotic supplementation, and the inclusion of spray dried
plasma. Zinc oxide has been used successfully to reduce the incidence and severity of
PWD. A dose of 2.88 mg/kg reduced the duration of infection to four days vs seven for
the control animals (n=15) in response to an oral 1x1010CFU/ml O149:K91:F4 challenge
(Owusu-Asiedu, 2003). However, this benefit was not seen with a ZnO concentration of
2.50 mg/kg and a more aggressive challenge consisting of three different challenge
strains on two occasions [(2x106CFU/square meter of 0147:K89(STb),
0141:K85(STb,VT2), 0149:K91,K88 (STa, STb, LT)] (Melin and Wallgren, 2002). Zinc
oxide is known to aid in intestinal development though alteration in bacterial composition
and may act as a growth promoter, though results seem to be conflicting for the level
needed for the effect (Hojberg, et al., 2005; Hedemann, et al., 2006; Melin and Wallgren,
2002; Davis, et al., 2004). It appears that higher levels of Zinc oxide are more protective
from (2500 ppm to 3000 ppm) (Davis, et al., 2004; Smith, et al., 1997). Combining
copper sulfate at 200 ppm plus 3000 ppm zinc oxide may provide a synergistic effect
(Smith, et al., 1997). This practice of heavy metal supplementation in the swine diet
raises environmental concerns however.
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Spray dried plasma in the post-weaning diet has been associated with increases in feed
intake and a reduction in the severity of PWD as well as bacterial shedding in the feces
(Owusu-Asiedu, 2003). The inclusion of spray dried plasma in a weaning pig diet
increased intestinal crypt depth and average daily gain in young pigs in response to ETEC
challenge (Owusu-Asiedu, 2003; Bosi, 2004). Inclusion of spray dried plasma as 8% of
the diet (the limit for economic feasibility), did not improve growth performance or
disease resistnace in response to an O139:K82 ETEC challenge (Van Dijk, et al., 2002).
Pre- and probiotic supplements has been used to promote intestinal health in the poultry
industry for some time. Unlike the use of these supplements in the poultry industry, the
intestinal tract of the pig is not a "clean slate" like hatchling birds, making it a more
difficult task to alter the bacterial flora. At weaning, the pig undergoes a shift in
microbiota, and preservation of the lactic acid bacteria present pre-weaning is thought to
promote a healthier intestinal environment. This may be accomplished by feeding milk
products such as whey protein or the use of lactic acid bacteria as a probiotic. A heat
killed, dried Enterococcus fecalis (EC-12) preparation at 0.05% of the diet was used as a
prebiotic dietary addition and was protective against STEC challenge (Tsukahara, et al.,
2007). At least nine other Enterococcus strains have been shown to have antagonistic
effects against K88 ETEC (Garcia-Galaz, et al., 2004). An Enterococcus fecalis (EK-13)
strain was fed as a probiotic to piglets and increases in lactic acid and propionic acid were
noted but no discernable increases in performance were observed (Strompfova, et al.,
2006). Liquid feed, allowed to ferment to produce lactic acid, was fed to piglets resulting
in increased growth and levels of lactic acid bacteria in the intestinal tract, which is
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thought to promote a healthy intestinal environment while excluding potential pathogens
(Canibe and Jensen, 2003; Hojberg, et al., 2003).
With most alternative therapies, there are drawbacks such as practicality, questionable
efficacy, or concern for the environment. At this time, antibiotic supplementation still
represents the best option for the control of PWD and growth promotion in the swine
herd. In the search for another solution however, we investigated the addition of Colicin
E1 to the swine diet.
Colicins
In perhaps the most ancient form of chemical warfare, bacteria produce chemicals to
eliminate competing species. Gram-negative bacteria can release a variety of chemicals,
including commonly used antibiotics to protect their ecological niche. Colicins are
peptides produced by E. coli and closely related species that kill other strains of E. coli.
Colicins may take the form of DNAses, RNAses, or pore formers. Structurally, all
colicins consist of three domains: (from the N terminus) a receptor recognition domain, a
translocation domain, and an activity domain.
Mechanism of Action
Colicins use two basic translocation mechanisms to gain entry into the target cell. Group
A colicins (A, E1-E9, K, L, N) use the Tol proteins for uptake into the host cell whereas
the Group B colicins (B,D,Ia,Ib, M,V) use the Ton system (Riley and Gordon, 1999).
The Ton and Tol translocation mechanisms are associated with nutrient uptake, such as
the B vitamin receptor (BtuB) or iron uptake in the target cell (Lazdunski, et al., 1998).
Colicins with divergent mechanisms of action such as the pore-formers, endonucleases,
or protein or cell wall inhibitors all utilize similar uptake systems (Lazdunski, et al.,
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1998) but recognize different receptors and indeed among colicins polymorphisms in the
plasmid do exist (Riley, et al., 1994). Colicin E1 and N are both group A pore forming
colicins that use the Tol translocation mechanism (Lazdunski, et al., 1998; Cao and
Klebba, 2002). Colicin E1utilizes the BtuB (vitamin B12) receptor for entry into the host
cell, while Colicin N uses the OmpF (porin) receptor for entry (Cao and Klebba, 2002).
Colicins may use one host cell structure for binding and another for entry and killing as
well. Colicin E1 does not require a porin to enter the host cell whereas Colicin N and all
other group A colicins do. All receptor binding and entry pathways have one thing in
common; however, they all include pathways that are essential to growth or maintenance
of the bacterial cell (Cao and Klebba, 2002).
Pore-forming colicins are a useful tool for chemists interested in bacterial membrane
transport and images of colicin structure and function have recently become available.
Despite their varying binding receptors and translocation techniques, there is one result
for the target bacteria. The ionic gradient of the bacterial cell is disrupted by the pore and
the cell is lysed.
Production of Colicins
E. coli produce colicins under conditions of nutrient depletion, overcrowding, osmotic
shock, UV light, or DNA-damaging antibiotics (Riley and Gordon, 1999, Spangler, et al.,
1985). When faced with these conditions, the bacteria react to the stress by undergoing
the SOS response (Konisky, et al., 1982). The LexA protein is the primary
transcriptional repressor of colicin synthesis and the SOS response. Under colicinogenic
conditions, LexA degradation stimulates cAMP and transcription of the colicin protein
(Kuhar and Zgur-Bertok, 1999). Colicin E1 possesses two SOS boxes in its promoter
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region (Kuhar and Zgur-Bertok, 1999), which may allow for different environmental
conditions to elicit different levels of induction. Kuhar (1999) compared strains
containing either Colicin K or E1 plasmids for their colicin production at different growth
stages, nutrient densities, and growth phases. While the Colicin E1 gene (cea) was
induced by an anaerobic environment, Colicin K (cka) was not, indicating slightly
different genetic control (Kuhar and Zgur-Bertok, 1999). The rate of release of Colicin
E1 was also shown to be greater than that of Colicin K in this study (Kuhar and Zgur-
Bertok, 1999)
The colicin producing cell is damaged by the production of the colicin and thus has
performed a seemingly altruistic act for the preservation of its relatives. If the benefit of
colicin production confers an ecological advantage, then it is of benefit for the cell to
maintain the plasmid (Riley and Gordon, 1999). When induced, the pore-formers release
the colicin through their cell membrane and cause an increase in permeability of their cell
membrane, resulting in cell damage (Cao and Klebba, 2002). The colicin producer is not
damaged by the action of the colicin itself but rather because of the increase in cellular
permeability needed to release the protein into the environment (Cao and Klebba, 2002).
Other bacterial cells that possess the plasmid to make the colicin, also have the immunity
protein so they survive in the event of colicin secretion by another cell (Alonso, et al.,
2000). The immunity protein provides the best defense against secreted colicins and is
part of the colicin plasmid which is constituitively produced by the cell in the bacterial
lipid bilayer (Espesset, et al., 1994). The immunity protein protects the cell from
endogenous colicin by binding to the colicin and preventing the C terminus from entry
into the cell membrane; thereby preventing voltage gating and subsequent loss of ionic
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gradient potential in the cell (Lindegerg and Cramer, 2000). Colicin immunity proteins
range in size from 85AA to 178AA and are highly specific for an individual colicin.
They work by altering the receptor binding motif slightly to stop the colicin encoded on
the plasmid from attacking "self" cells (Alonso, et al., 2000). Other bacteria may be
resistant or tolerant to colicin invasion as well (Alonso, et. al, 2000). Bacteria showing
resistance to colicin may have mutated their receptors just enough to evade colicin
binding (Alonso, et. al, 2000). Colicins show remarkable specificity for their targets, as
even a one amino acid mutation in their structure can prevent colicin binding (Alonso, et
al., 2000; Cao and Klebba, 2002). Changes in the translocation structure can result in
colicin tolerance. Colicin tolerance exists when mutations Tol and Ton transport systems
are altered in such a way that the bacteria use a slightly different transportation system to
actively bring in nutrients. This tolerance is said to be overcome by simply adding more
colicin to the mix, however (Alonso, et. al, 2000). The active transport mechanisms
needed to bring in nutrients are most likely essential to the target cells existence.
Colicin Ecology
How many bacteria have the propensity to produce colicins and what type of colicins are
most prevalent is still a matter of debate. Colicin-producing bacteria are often estimated
at 30-40% of those cultured (reviewed, Riley and Gordon, 1999) in the natural population
in the colon, though ranges are from 9% to 82% (reviewed, Smarda and Obdrzalek,
2001). This amount of variance, and the variety of methods used for the detection of
colicinogenic strains, makes it difficult to know how prevalent colicin producing bacteria
are in the environment. In a 2001 study, E. coli strains were isolated from both healthy
persons and those who were suffering from intestinal distress (Smarda and Obdzalek,
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2001). In hosptial patients infected with Salmonella, or afflicted with ulcerative colitis or
tumors, there was no apparent trend of colicinogenic strains recovered, but in the case of
hemolytic urinary tract infections there were significantly more colicin producers
recovered (Smarda and Obdzalek, 2001), though which type were not identified. Among
other urinary tract isolates, 44% were colicin producers with Colicin V being the most
commonly isolated (Riley and Wertz, 2002). In 266 human fecal isolates, 42% were
colicinogenic in a 2006 study (Gordon and O’Brien, 2006). Of those, Colicins Ia and E1
the most prevalent at 9%, followed by M, E7, K, E2, and B all at less than 5%. Of the
102 strains, induced by mitomycin C to make colicin, 41% made two and 16% made 3
different colicins (Gordon and O’Brien, 2006). The authors conclude that E. coli strains
that carry more than one colicin may benefit from carrying an SOS induced colicin (Ia)
along with another that is induced by iron depletion (V).
The relationship between colicogeny and pathogenicity is a curious one as well. Colicin
V has been associated with an increase in virulence in urinary tract infection isolates
(Waters and Crosa, 1991) and transformation with a Colicin V-containing plasmid can
result in an increase in virulence of the strain in chickens (Wooley et al., 1994).
Colicinogenic strains were more commonly recovered in cases of pyelonephritis and
cystitis than when compared to when urinary shedding of the bacteria was caused no
clinical disease (Riley and Wertz, 2002). Colicin-producing strains may indeed be more
fit from an ecological perspective.
If a colicinogenic strain can colonize a new niche, such as happens with a systemic,
rather than localized infection, the strain is at a selective advantage. On the other hand,
colicins are only produced at low levels at “normal” conditions. The colicin production
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is only induced in conditions of nutrient scarcity or when the cell senses impending doom
such as DNA damage or UV light (Riley and Gordon, 1999). When entering a new
environment the cell does not know what other bacteria are resistant to their colicin.
From a bacterial ecology standpoint, colicin producing strains always eliminate colicin
sensitive strains, but E. coli resistant to colicin out compete producers because of the cost
of making the colicin puts producers at a disadvantage. Without the presence of colicin
producers though in an ecological niche, colicin sensitive strains beat out resistant strains
because resistant strains have had to modify their nutrient uptake systems in order to
avoid colicin insertion. This then makes resistant strains less efficient and at an
ecological disadvantage (Kirkup and Riley, 2004; Riley and Gordon, 1999, Riley and
Gordon, 1992).
Colicins as Antimicrobial Agents
Due to their efficient bactericidal action colicins make an attractive target for use as an an
antimicrobial agent (Gillor, et al., 2004). Colicins have been used in at least one human
application. Trautner, et al. (2002), used E. coli strains which produce Colicin E2 (a
DNA endonuclease) to prevent infection causing E. coli from colonizing urinary
cathethers. The food safety applications of Colicin E1 have been investigated as well
with the possible application of a carcass spray to reduce the levels of Listeria
moncytogenes on meat (Patton et al., 2007).
In the search for alternatives to antibiotics in animal production, colicins have been
approached as a potential option for control of pathogens of food safety concern in the
animal as well. Animal studies exploring the use of direct fed colicins to control a
bacterial population are few. In a 2001 study, 20 different colicin-producing strains were
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induced to produce colicin and tested against Shiga toxin-producing E.coli under aerobic
and anaerobic conditions, and in the presence of rumen fluid (Jordi, et al., 2001).
Colicins E1 and K were the most effective under anaerobic conditions and when cultured
with rumen fluid (Jordi, et al., 2001). Schamberger, et al., (2004) directly fed eight live
Colicin E7 producing strains to cattle, after screening 22 colicin producing strains for
their inhibitory level vs E.coli O157 (Schamberger et al., 2004; Diez-Gonzalez, et al.,
2002). These live bacterial cultures were fed at a level of 1x108CFU/day and
significantly reduced fecal E.coli O157:H7 shedding. The economic feasibility of using
colicins for the prevention of disease in animals has yet to be determined. However, the
purification costs associated with feeding a pure protein at this time are prohibitive.
Yeast Recombinant Protein Production
Pichia pastoris
First recognized by Philips Petroleum Company for its ability to use methanol as its sole
carbon source in the 1970’s, Pichia pastoris was originally cultured to be an alternative
animal protein source (reviewed, Macauley-Patrick, 2005). Subsequently, after the
development of expression vectors, P. pastoris was exploited for heterologous
recombinant protein expression and has since been available from Invitrogen in kit form.
As compared to E. coli expression systems, the more complex eukaryotic metabolism of
P. pastoris allows for post-translational modifications such as glycosylation,
isomerization, and the addition of functional groups (Daly and Hearn, 2005). Unlike E.
coli which require maintenance of an antibiotic resistance plasmid, chromosomal
integration occurs in yeast transformation and it is not lost after generations.
Recombinant Yeast Applications
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Recombinant yeast have been used for applications in animal health and nutrition
previously. Phytases, such as APPA2, have been included in the swine diet to improve
phosphorus utilization (Lee, et al., 2005). Porcine epidermal growth factor (EGF) was
expressed in Pichia pastoris supernatant and fed to pigs at 1.5mg/kg (Lee, et al., 2006).
This addition to an early-weaned pig diet over a 28 day period increased feed efficiency
by 30% and stimulated an increase in serum IgA (Lee, et al., 2006). Pichia pastoris was
also used to express porcine somatotropin into the supernatant (Ouyang, et al., 2003).
The recombinant somatotropin showed a cell proliferation effect in Nb2 cells, indicative
of somatotropin but injection of the peptide into gilts did not trigger the expected
enhancement of growth performance and feed efficiency (Ouyang, et al., 2003). The LTb
subunit of the labile toxin has been expressed in Pichia pastoris and the secreted, purified
protein was shown effective at eliciting an immune response in chickens against cholera
toxin and LT involved in ETEC associated diarrhea (Fingerut, et al., 2005).
In addition to the animal applications for the recombinant, yeast produced, colicin, there
may be applications for the technology in human medicine and food safety as well.
Conclusion
Post-weaning diarrhea remains a threat to swine production. With the emergence of
antimicrobial resistant bacteria in the swine population and the perceived threat of the
transfer of these bacteria to the human population, alternatives to the antibiotics currently
used in swine feed must be developed. Other therapies such as zinc oxide and copper
supplementation are not ideal because of environmental concerns of excesses of these
minerals in the waste and the recent reports of delay of PWD infections rather than their
elimination. Pre- and probiotic supplements are also viable alternatives under
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development that may offer some promise. The addition of colicins to the post-weaning
swine diet, perhaps in combination with probiotic addition or in the recombinant yeast,
may be a viable option for swine production.
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CHAPTER 1
DIETARY INCLUSION OF COLICIN E1 IS EFFECTIVE IN
PREVENTING ESCHERICHIA COLI F18 POST-WEANING
DIARRHEA IN PIGS
S.A. Cutler, S.M. Lonergan, N. Cornick, A.K. Johnson, and C.H. Stahl
A journal article submitted and under revision to Antimicrobial Agents
and Chemotherapy
Abstract
With world-wide concern over the use of antibiotics in animal agriculture and their
contribution to the spread of antibiotic resistance, alternatives to conventional antibiotics
are needed. Previous research in our lab has shown that Colicin E1 (ColE1) is effective
against certain E. coli strains responsible for post weaining diarrhea (PWD) in vitro. In
this study we examined the efficacy of dietary inclusion of ColE1 in preventing
experimentally induced F18+ enterotoxigenic E. coli (ETEC)- caused PWD. Twenty-
four weaned pigs (23 days of age), identified by genotyping to be susceptible to E. coli
F18 infections, were individually housed and fed diets containing either 0, 11, or 16.5 mg
ColE1/kg diet. Two days after the start of the trial, all animals were orally inoculated
with 1×109 CFU each of 2 F18+ ETEC strains isolated from pigs with PWD. The dietary
inclusion of ColE1 decreased the incidence and severity of F18+ ETEC-caused PWD and
improved the growth performance of the piglets. Additionally, prevention of PWD by
the dietary addition of ColE1 reduced the expression of IL1 and TNF mRNA in ileal
tissue from these animals. Dietary inclusion of ColE1 may be an effective alternative to
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conventional antibiotics in weaning pig diets for the prevention of PWD caused by F18+
ETEC.
Introduction
Post-weaning diarrhea (PWD) is a serious threat to the economic success of the swine
industry, due both to losses as a result of mortalities, as well as reduced growth
performance of surviving pigs. It is estimated that 50% of piglet mortality worldwide is
attributable to the causative agent of PWD, enterotoxigenic Escherichia coli (ETEC)
(Fairbrother, et al., 2005). The ETEC strains most commonly associated with PWD in
pigs possess the F4 or F18 fimbrial type (Fairbrother, et al., 2005, Zhang, et al., 2007).
As a result of the significant impact that F18+ ETEC infections can have on pig
production, prophylactic antibiotics are frequently included in the diets of young pigs in
an attempt to prevent ETEC colonization and the resulting PWD. An estimated 78% of
large swine farms in the U.S. include subtherapeutic antibiotics in the diets for young
pigs (USDA, 2001). Despite the use of antibiotic prophylaxis, 40.7% of these farms
reported an incidence of diarrhea caused by E. coli infections (USDA, 2001). The lack of
effective PWD prevention with the use of prophylactic antibiotics is not surprising,
because of the frequency and spectrum of antibiotic resistance seen among ETEC strains
(Choi, et al., 2002; Maynard et al., 2004; Lanz, et al., 2003). It is expected that antibiotic
resistance will further increase among these strains, based on the overall increase in
resistance to antibiotics by ETEC over the last 20 years (Maynard et al., 2004).
With worldwide concern over the use of prophylactic antibiotics in animal
agriculture and its contribution to the spread of antibiotic resistance (FDA, 2003;
Maynard, et al., 2004), the development of alternatives to conventional antibiotics is
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urgently needed to protect swine from these E. coli infections. Public concerns
surrounding the antibiotic resistance issue led to the elimination of prophylactic antibiotic
use in animal agriculture in Denmark (reviewed, Stein, 2002). This cessation of the use
of prophylactic antibiotics in pig production caused a sharp increase in the rate of PWD
and a 30% increase in piglet mortality (reviewed, Stein, 2002). These infections led to an
increase in veterinarian prescribed antibiotic use in Denmark’s swine industry (Jensen,
2006). The switch from growth promoting or prophylactic antibiotic usage to only
veterinary prescribed therapeutic usage resulted in a very modest reduction in total
antibiotic usage in Denmark’s swine industry (Jensen, 2006). In order to realize a true
reduction in antibiotic use in animal agriculture, effective alternative therapies must be
developed.
A potential alternative to conventional antibiotics that holds a great deal of
promise are colicins. Colicins are a class of bacteriocins produced by, and effective
against, E. coli and closely related bacteria (Fredericq, 1957). These proteins are
particularly attractive for use as an alternative to conventional antibiotics for the control
of E. coli caused PWD for several reasons. We have previously shown them to be
effective against some strains of ETEC responsible for PWD in vitro (Stahl, et al., 2004),
and other work has demonstrated that ColE1 is effective against a wide range of E. coli
(Yang, et al.,2007; Murinda, et al., 1996; Jordi, et al., 2001; Schamberger and Diez-
Gonzalez, 2002). They are not related to any antibiotics that are currently being used in
human medicine. Also, colicins would not be absorbed intact by the animals, thereby
eliminating concerns over antibiotic residues in meat, and colicins could be effective at
low enough concentrations so as not to significantly alter the nutrient density of the diet.
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The objective of this study was to determine the efficacy of dietary inclusion of Colicin
E1 in preventing PWD due to F18+ ETEC.
Materials and Methods
Colicin Production
Colicin E1 was produced and purified to homogeneity according to the method of Stahl,
et al. (28). Briefly, a Colicin E1 producing strain of E. coli was grown in LB and colicin
production was induced by the addition of Mitomycin C (EMD Biosciences, San Diego,
CA) to the media. The ColE1 was purified from the cell free supernatant by ion
exchange chromatography, first utilizing DEAE cellulose (Sigma-Aldrich, St. Louis,
MO) and then further purifying the protein utilizing Q sepharose (GE Healthcare,
Piscataway, NJ). The purity of the Colicin E1 used in this study is estimated by
densitometry at over 95% and the purity of this preparation has been visualized by SDS-
PAGE previously (Patton et al., 2007).
ETEC challenge strains
Escherichia coli F18 strains 2144 (O147:NM) and S1911 (O139) were used as challenge
strains. Strain S1191 was isolated from a pig with edema disease and produces heat
stable toxins STa, STb, and Shiga toxin 2e and is chloramphenicol resistant. Strain 2144
was a field isolate that was made nalidixic acid resistant and produces the toxins STa and
STb. Both strains were grown overnight as pure cultures in LB at 37°C with shaking.
They were then individually diluted to an OD600 = 0.1 in fresh LB and allowed to grow to
an OD600  1. The cultures were then centrifuged at 4,000 × g for 10 min at 4ºC. The
bacterial pellets were resuspended in 20% dextrose and 5% non-fat dry milk. The
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challenge dose consisted of an equal amount of each strain and was determined by serial
diluting and plating to provide a total of 2x109 CFU/0.5 ml oral dose.
Animals
All of our protocols involving animals were approved by the Institutional Animal Care
and Use Committee of Iowa State University. The 24 barrows (castrated pigs) utilized
were obtained from the Iowa State University Swine Nutrition Farm and were determined
to be susceptible to E. coli F18 based on a restriction fragment length polymorphism test
described by Frydendahl et al. (2003). Briefly, genomic DNA was purified (DNeasy Kit,
Qiagen, Valencia, CA) from pig tail clippings and primers (forward -
TTGGGAACCAGATGGGACAGTATG and reverse -
CCCGCCAAGGAGCGTGCCTGTCTA) were used to amplify a 162 bp section of the 1,
2 fucosyltransferase enzyme by PCR (24). The 162 bp PCR product was then digested
using HhaI (New England Biolabs, Ipswich, MD) and the polymorphism was determined
by size comparison on a 3% agarose gel.
Pigs were weaned at 17 days of age and allowed to adjust to solid food (TechStart 17-25,
Kent Feeds, Muscatine, IA). At 21d of age, the pigs were grouped by body weight (n=8)
and transferred to individual pens. Pigs were given 2 d to adjust to individual housing
before the experimental diets were fed. The basal diet for all of the experiments was corn
and soy based and contained no animal products (26% crude protein, 3.51 kcal/kg). This
diet met or exceeded the nutrient requirements of these pigs based on the NRC (1998)
recommendations. Either 0 (control), 11, or 16.5mg of purified ColE1 (supplied at 10
mg/mL in 10 mM Tris, pH 7.6) was added per kg to the basal diet, and the diets were
then pelleted at low temperature (Purina TestDiet, Richmond, IN). The pelleted rations
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were provided to the pigs twice daily at a rate which exceeded consumption for each
animal (approximately 500 g/d). Unconsumed feed was weighed daily and feed intake
was determined.
After receiving the experimental diets for 2 d, all animals were orally inoculated with the
two F18+ ETEC strains and their fecal scores were recorded. Fecal scores were
determined (0 = dry, hard, and well formed feces; 1 = soft, but formed feces; 2 = pasty
and green/brown in color; 3 = viscous and light in color, episodic; 4 = fluid and light in
color, episodic; 5 = watery and continuous) twice daily after the bacterial challenge.
Fecal samples were obtained 2 d prior to the ETEC challenge and daily after the
challenge by inserting a 10 µl fecal loop (Fisher Scientific, Pittsburgh, PA) into the
rectum. These samples were immediately diluted in 5 ml of sterile PBS. Serial 10 fold
dilutions, (up to 1:100,000) were plated onto MacConkey’s (MAC, Difco, Franklin
Lakes, NJ), MAC + chloramphenicol, and MAC + nalidixic acid agar plates for CFU
determination. Four days post challenge, all pigs were euthanized by captive bolt and
tissue samples were collected. Ileal sections (approximately 10 cm each) were collected
from each pig for RNA extraction, and E. coli enumeration. Additionally, rectal and
cecal contents were collected for E. coli enumeration.
Gene expression
Isolation of RNA from the ileum was performed utilizing a whole ileal homogenate and
the RNeasy kit (Qiagen, Valencia, CA). Genomic DNA was eliminated from the
extracted total RNA using the DNA-free kit from Ambion (Austin, TX) according to the
manufacturer’s instructions. The RNA was reverse transcribed using Superscript III
(Invitrogen Life Technologies, Carlsbad, CA), and then removed from the resulting
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cDNA by incubation with E. coli RNase H (Invitrogen) according to the manufacturer’s
instructions. Concentrations of cDNA were determined utilizing the Quant-it kit
(Invitrogen), and the cDNA samples were then stored at -80°C until analysis by real-time
PCR. The levels of interferon (IFN), interleukin 10 (IL10), interleukin 8 (IL8), tumor
necrosis factor  (TNF ), tumor necrosis factor  (TNF), interleukin1 (IL1), and
inducible nitric oxide synthase (iNOS) expression were semi-quantitatively determined
by real-time PCR using the MyiQ™ Single Color Real-Time PCR Detection System and
SYBR Green (Bio-Rad Laboratories; Hercules, CA). Thermocycling conditions included
45 cycles of 30s of melting at 95ºC followed by 30s of annealing and extension at 60ºC.
Following amplification, all samples were subjected to a melt curve analysis to insure
that only a single product was produced. Primer oligonucleotides (Table 1) were
designed using “PrimerQuest” software available from Integrated DNA Technologies
(Coralville, IA). All primer sets were validated to amplify only the sequence of interest
and to do so in a linear fashion over a 2 log range of cDNA concentrations. The data
from all samples were normalized to cDNA concentration prior to statistical analysis.
Bacterial enumeration
Enumeration of E. coli from the ileal mucosa, cecal content, and rectal content samples
was performed as follows. Samples were weighed, diluted 1:2 with buffered peptone
water and placed in a stomacher blender (Seward Stomacher 80, Worthing, UK) for 30
seconds. The samples were then serially diluted over a 4 log range at a 1:200 starting
dilution for tissues and 1:500 for fecal samples. Ten µl of each dilution was plated in
duplicate on MAC, MAC + chloramphenicol (30 µg/ml), and MAC + nalidixic acid (50
µg/ml) agar plates. Plates were incubated for 16 hours at 37°C and the countable dilution
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was then recorded. The limit of detection for our enumeration was 1×103 CFU/g of tissue
and 1×104 CFU/g of feces.
Statistical analysis
Statistical analysis of the data was performed with Statistical Analysis Software version
9.1 (SAS, Cary, North Carolina) utilizing the GLM procedure. Treatment was considered
a fixed effect, and for growth parameters initial body weight was considered a covariate
in the analysis. For the bacterial enumeration data, samples that were below the limit of
detection were ascribed a value of 1 CFU less than our limit of detection for the
calculation of means. All values for bacterial recovery are Log10 least squares means.
Results
Fecal scores
Prior to bacterial challenge, none of the pigs showed any indication of diarrhea or loose
stool. There were no significant differences in fecal scores among the treatment groups
until 48 h post-challenge (Figure 1). At this point the group fed the control diet had a
mean fecal score of 2.38 which was higher (P < 0.06) than that of the group fed the 16.5
mg ColE1/kg diet (mean score of 0.5) (Figure 1). Over the entire study, the control group
had significantly higher (P < 0.05) average fecal score than the high dose (16.5 mg/kg
feed) ColE1 group (2.1 vs. 0.59, respectively). The low dose (11mg/kg) ColE1 group
also had higher (P < 0.05) average fecal scores than the high dose ColE1 group, and these
were not significantly different from those of the control pigs. These differences in group
fecal scores were caused by an increase in the incidence of diarrhea (fecal scores  4)
among the control group pigs. In the control group 1, 4, and 5 out of the 8 pigs had
diarrhea after 24, 48, and 72h post-ETEC inoculation, respectively. Among the pigs fed
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the low dose of ColE1, no animals had diarrhea 24h post-inoculation, however 3 and 4
pigs had diarrhea at 48 and 72h post-challenge, respectively. None of the pigs fed the
high dose of ColE1 had any incidence of diarrhea at any time during the experiment.
Growth performance
Dietary inclusion of ColE1 had a significant effect (P < 0.05) on the growth performance
of the pigs in this study (Table 2). From the time of E. coli challenge until the
completion of the study, pigs fed the control diet gained an average of 380 g while the
pigs receiving either the low or high dose of ColE1 in their diets gained 540 and 940 g,
respectively (Table 2). Although the animals fed the control diet gained the least body
weight over the course of the study, they consumed significantly (P < 0.05) more feed
than either of the groups fed diets containing ColE1. The control group animals averaged
a total consumption of 1.54 kg of diet, while the ColE1 treated pigs ate 1.22 kg and 1.44
kg, for the low and high dose ColE1 diets, respectively. Although there were significant
differences in both body weight gain and feed consumption, there was not a significant
difference in feed conversion efficiency (body weight gain/feed intake, P < 0.19) among
any of the treatment groups. In the control group, 2 of the animals lost weight
(approximately 400 g each) over the length of the study, causing a negative body weight
gain which resulted in a tremendous variation in the feed conversion efficiency for this
group.
Bacterial enumeration
Fecal cultures
There were no colonies isolated on the agar plates containing either chloramphenicol or
nalidixic acid from any samples prior to the F18+ ETEC challenge. At 24h post-
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inoculation, levels of both total coliforms and the ETEC 2144 challenge strain recovered
in the feces were higher (P < 0.05) in the control animals compared with both groups of
ColE1 fed pigs (Table 3). There were no significant differences between treatment
groups in the recovery of the ETEC S1191 challenge strain at the first day post challenge
but in the subsequent day there was a reduction in the high dose ColE1 group as
compared to the controls (P < 0.05). By the last day of fecal sampling, the levels of the
S1191 strain had dropped below our detection limit for most of the animals regardless of
dietary treatment (16/24) and there were no significant differences in the amount of the
2144 strain recovered.
Tissues
In the ileum, both treatment groups averaged lower levels of both challenge strains as
compared to the controls (Table 4). A trend existed for higher total coliforms in the low
group as compared to the controls (P < 0.08). There were no significant differences in
the recovery of bacteria from the cecal samples. The S1191 strain was only recovered in
cecal samples from 3 of the 8 animals in the high dose ColE1 group compared with 6 and
4 animals in the control and low dose ColE1 treatment, respectively. In the rectum,
similar levels of total coliforms and 2144 were recovered for animals in all groups.
Significant differences in the levels of the S1191 strain were seen with colicin treatment.
Control animals had higher levels of the S1191 strain recovered in their rectal samples
compared with either colicin treated group. Interestingly, the low dose ColE1 group had
significantly lower (P < 0.05) levels of this bacteria compared to the high dose group.
Gene expression
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The expression of TNF mRNA in ileal tissue was higher (P < 0.05) in the control
animals than in either of the ColE1 treated groups (Figure 2). The levels of IL1 mRNA
were highest in the low ColE1 supplemented group (6 fold higher than in the controls (P
< 0.05), whereas the high ColE1 group had nearly undetectable levels (Figure 3). The
levels of expression of both TNF and iNOS tended (P < 0.1) to be greater in control
animals and there were no significant differences in the expression of IFN, IL8, or IL10,
in the ileum due to colicin treatment.
Discussion
We examined the efficacy of ColE1 in preventing F18+ ETEC caused post-weaning
diarrhea (PWD) because PWD is a major bacterial threat to the economic sustainability
of swine production. This disease has been estimated to be responsible for as much as
50% of the economic losses seen in the production of weaned pigs (Hani, et al., 1971;
Fairbrother, et al., 2005). In herds with PWD, up to 2% mortality (USDA, 2001) in
weaning pigs can be seen, but of greater economical significance is the morbidity and
reduction in growth performance in the pigs that survive these infections. This lost
productivity costs the U.S. swine industry several million dollars each year. Although
there is a need for alternatives to conventional antibiotics, the development of compounds
to combat ETEC-associated PWD is beset with difficulties including having an adequate
experimental model of ETEC infection. In the field, PWD is a multifactorial disease and
interventions must therefore, be tested against a challenge dose that is high enough to
produce diarrhea but not toxic immediately post-challenge. Establishing a good
challenge model for this disease has proven to be difficult. Madec et al.utilized four
strains of ETEC and several different dosing methods in six trials utilizing a total of 168
34
specific pathogen free piglets and was only able to generate clinically significant,
although transient, diarrhea in 50% of animals (Madec, et al., 2000). Using a viral co-
infection such as transmissible gastroenteritis (TGEV) or rotavirus that leads to
immunosuppression and intestinal membrane disruption can also lead to an increase in
experimental ETEC infection rates (Cox, et al., 1991; Benfield, et al., 1988; Girard, et al.,
2005; Nagy, et al., 1992). While a co-challenge model can increase the success rate of
experimentally reproducing PWD, it also adds a potential confounding effect particularly
if the viral infection alone causes reduced growth performance. An alternative to the
viral co-infection model that has also been shown to increase the success of an ETEC
bacterial challenge is modification of the post-weaning diet. Alterations of the protein
source(s) utilized in the post-weaning diet (shifting away from animal-based protein
sources to soy-based) can significantly affect the susceptibility of the pigs to ETEC
infection due to a transient intestinal inflammatory response (Bosi, et al., 2004; Dreau, et
al., 1994). While both viral co-challenges and dietary alterations can increase infection
rates in experimentally induced PWD models, identifying the genetic susceptibility of the
animals may offer the most efficient way to increase infection rates in a challenge model.
With the use of pre-screening for a F18 receptor polymorphism, the rate of infection can
be increased from 5.9% in the F18 resistant genotype pigs to 87% in those that are
genetically susceptible (Frydendahl, et al., 2003). In this study, we utilized only
genetically susceptible animals, as well as a weaning diet that contained no animal
protein and as a result a majority of the protein in the diet was from soybean meal. With
this model we achieved over a 60% infection rate in control animals with no mortality
after 5 days, no viral co-infection, and an easily-performed one-time oral challenge.
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Although our high dose of ColE1 (16.5mg/kg of diet) was able to eliminate all clinical
signs of PWD, our low dose of ColE1 was only able to slightly delay the onset of PWD.
The level of reduction of the challenge strains of E. coli that reached the ileum as a result
of feeding the ColE1 may have been the determining factor in the prevention of the
development of clinical disease. Colicin fed animals had significantly lower (P < 0.04)
fecal shedding of the 2144 challenge bacteria at 1 day post-challenge (Table 3). While
this suggests that the addition of colicin to the feed significantly reduced the amount of
viable bacteria that reached the distal end of the small intestine, it also demonstrates that
our colicin dose was not sufficient to completely eliminate the challenge strains. At the
completion of the study there were no significant differences based on colicin treatment
on fecal shedding of either of the ETEC challenge strains. We would not anticipate that
the feeding of ColE1 would have an effect on reducing the colonization of the ETEC
strains if they reached the ileum in a viable state, since ColE1is sensitive to proteolysis
(Cavard, et al., 1989; Bowles, et al., 1981; Brey, et al., 1982). It is likely that not all of
the E. coli in our large challenge dose would be killed by the ColE1 present in the digesta
prior to the inactivation of the ColE1 by proteolysis, but it appears that enough was
eliminated as a result of the high dose ColE1 supplementation to prevent disease. The
intestinal gene expression data also suggests that fewer of the challenge bacteria reached
the intestine in a viable state and were therefore not able to colonize the ileum thus
leading to diarrhea in the pigs. This is supported by the lower expression (P < 0.05) of
IL1 and TNF mRNA in the ileal tissue of pigs fed the high ColE1 diet compared with
the control (Figure 3). Interleukin 1 is primarily secreted by macrophages and activates
lymphocytes during an immune response. While the concentration of IL1 message was
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significantly lower in the ileal tissue of the pigs fed the high dose of ColE1 compared
with the control pigs, pigs in the low ColE1 dose group had mRNA levels that were over
6 fold higher than those of the control. At the time of tissue collection there was no
longer any significant difference in fecal score between the low dose and the control
groups and this elevated expression may be indicative of a delay in the inflammatory
response as a result of the ETEC challenge. This would be reasonable since there
appeared to be a delay in the onset of PWD with the low dose ColE1 fed pigs compared
with the control animals. An increase in IL1 gene expression has been correlated with
porcine enteropathogenic E. coli challenge (Girard, et al., 2005), although the associated
increase in IL6, IL8, and IL10 seen by Girard et al. were not noted in our study.
Regardless of the dose, reduced levels (P < 0.06) of expression of TNF were seen
among pigs receiving the ColE1 containing diets (Figure 2). TNF, also known as
lymphotoxin, is a primary effector of NO production and is associated with inflammatory
responses related to T cell recruitment (Ferrante, et al., 1990). The lower levels of
expression of TNF and IL1 in the ileal tissue of pigs fed the high dose of ColE1
compared with the control animals suggests that ColE1 was able to significantly reduce
the bacterial load that initially reached the ileum in these animals; thereby reducing the
inflammatory response to this ETEC challenge.
While other researchers have examined the efficacy utilizing colicin producing bacterial
cultures as probiotics for cattle in order to reduce E. coli O157 contamination
(Schamberger, et al., 2004), we are the first, to our knowledge, to examine a purified
colicin as a feed component for the prevention of an ETEC infection. We have
demonstrated with growth performance data, clinical indicators of PWD, and intestinal
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gene expression that the inclusion of ColE1 can prevent experimentally induced PWD.
The efficacy in preventing PWD at a 16.5mg/kg diet level of dietary inclusion, suggests
that ColE1 warrants further evaluation as a potential alternative to conventional
antibiotics for use in weaning pig diets. This protein may also have significant
implications for human food safety as well, since the efficacy of ColE1 against many
ETEC of concern for human food safety has been well-documented (Callaway, et al.,
2004; Jordi, et al., 2001; Murinda, et al., 1996).
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Table 1. Primer sets for semi-quantitative real-time PCR analysis of intestinal gene
expression.
Gene name Primer sets
Inducible Nitric Oxide Synthase (iNOS) F: GGACGTACGAAGTGACCAACC
R: GAACGTACGAAGTGACCAACC
Interleukin 1  (IL1) F: TGAAGAAGAGCCCATCGTCCT TGA
R: TGCACAAAGCTCATGCAGAACACC
Tumor Growth Factor  (TGF) F: AGGCCGTACTGGCTCTTTACAACA
R: TTGGTTGCCGCTTTCCACCATTAG
Interleukin 10 (IL10) F: AAGACGTAATGCCGAAGGCAGAGA
R: TGCTAAAGGCACTCTTCACCTCCT
Interferon  (IFN) F: ATGACTTCCAAACTGGCTGTTGCC
R: TATGCACTGCGATCGAAGTTCTGC
Interleukin 8 (IL8) F: ATGACTTCCAAACTGGCTGTTGCC
R: TATGCACTGGCATCGAAGTTCTGC
Tumor necrosis factor  (TNF) F: GCCCACGTTGTAGCCAATGTCAAA
R: GTTGTCTTTCAGCTTCACGCCGTT
Tumor necrosis factor  (TNF) F: AGATCAGCTGTCCAGACACACAGA
R: TAGAGCGAAGGCTCCAAAGAAGAC
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Table 2. Effect of dietary inclusion of Colicin E1 on growth performance of weaning
pigs.
Treatment Weight gain, kg SEM Feed intake, kg SEM Feed Efficiency1 SEM
Control 0.38a 0.16 1.58a 0.062 3.60 0.94
Low 0.54a 0.16 1.22b 0.062 2.83 0.74
High 0.94b 0.16 1.40b 0.062 1.98 0.74
a,b value within a column not sharing a common superscript are different (P < 0.05)
1 Feed efficiency is defined as feed intake/weight gain.
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Table 3. Effect of Colicin E1 on E. coli levels in the feces of weaning pigs. Values are
Log10.
Colicin
Dose
Total
coliforms SEM
Strain 2144,
NALR SEM
Strain S1191,
CAMR SEM
1 day post-challenge
Control 7.8a 0.4 7.1a 0.4 6.0a 0.3
Low 6.8ab 0.4 5.7b 0.4 4.8b 0.3
High 6.5b 0.4 5.6b 0.4 4.7b 0.3
2 days post-challenge
Control 8.0 0.4 6.9 0.6 5.7 0.3
Low 8.1 0.4 6.2 0.6 5.0 0.3
High 7.3 0.4 5.4 0.6 4.9 0.3
3 days post-challenge
Control 8.8 0.4 7.5 0.7 4.7 0.2
Low 8.9 0.4 6.6 0.7 4.9 0.2
High 7.8 0.4 6.0 0.7 5.2 0.2
a,b values within a day and column not sharing a common superscript are significantly
different (P < 0.05).
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Table 4. Dietary inclusion of Colicin E1 affects bacterial recovery in the ileum of
weaning pigs. Values are Log10.
Colicin
Dose
Total
coliforms SEM
Strain 2144,
nalR SEM
Strain S1191,
camR SEM
Control 8.2a 0.4 6.5 0.8 4.4a 0.3
Low 6.8b 0.4 5.1 0.8 3.1b 0.3
High 6.8b 0.4 4.8 0.8 3.2b 0.3
a,b value within a column not sharing a common superscript are significantly different (P
< 0.05).
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Figure 1. The percentage of pigs with diarrhea indicative of a fecal score higher than
three. The low diet had 11 mg/kg ColE1, the high diet 16.5 mg/kg, and the control had
no addition.
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Figure 2. Relative gene expression, normalized to cDNA concentration (25 ng/reaction),
of tumor necrosis factor beta (TNF) in intestinal mucosa of pigs fed 16.5 mg/kg Colicin
E1 (high), 11 mg/kg Colicin E1 (low) or a basal diet. a,b indicate P < 0.05
TNF Beta
0
5
10
15
20
25
30
R
el
a
tiv
e
G
en
e
Ex
pr
es
sio
n
Control Low High
a
b b
44
Figure 3. Relative gene expression, normalized to cDNA concentration (25 ng/reaction),
of Interleukin 1 Beta (IL-1) in intestinal mucosa of pigs fed 16.5 mg/kg Colicin E1
(high), 11 mg/kg Colicin E1 (low) or a basal diet. a,b indicate P < 0.05
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CHAPTER 2
DIETARY INCLUSION OF COLICIN E1 IS EFFECTIVE
AT PREVENTING ESCHERICHIA COLI F18 POST
WEANING DIARRHEA IN PIGS-LONGER DURATION
TRIAL
S.A. Cutler, S.M. Lonergan, N.A.Cornick, and C.H. Stahl
A manuscript in preparation for the Journal of Animal Science
Abstract
Post-weaning diarrhea continues to cause significant economic losses in swine
production. We have previously shown the efficacy of feeding Colicin E1 to recently
weaned pigs as an alternative to sub therapeutic antibiotics to prevent post-weaning
diarrhea. A highly purified preparation of Colicin E1 was included at 20 mg/kg for two
weeks post-weaning and then removed from the diet for an additional two-week period to
determine if withdrawal would have any deleterious side effects. A seeder model was
employed for enterotoxigenic Escherichia coli challenge. Eight pigs were orally
challenged with 109CFU/g of an ETEC strain previously isolated from piglets with PWD.
Two animals, paired by body weight, that exhibited severe diarrhea two days post-
challenge were placed into pens of piglets that were either fed a diet containing 20mg/kg
Colicin E1 or a basal diet with no supplementation. All challenged animals were
susceptible to ETEC as determined by PCR/RFLP. In addition, a group of littermates
were fed the same diets, in the absence of ETEC challenge to investigate any possible
changes in body weight gain between the test diet and control.
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In the first week after the seeder pigs were introduced into the ColE1 fed and control fed
pens, 6 out of 9 control animals failed to gain over 300 g as compared to 2 of 10 in the
ColE1 group. Four of the control animals lost weight and two of those pigs lost more
than 10% of their initial body weight. The diarrhea persisted for up to two weeks in the
control animals. Gene expression of ileal mucosa showed differences in intestinal
development and the persistence of the inflammatory response after ETEC challenge. The
challenged control animals had higher levels of TNF four weeks post ETEC exposure.
Expression of COX2 and PGHS were highest in the ColE1 fed ETEC challenged animals,
suggesting an upregulation of prostaglandins to preserve membrane integrity in recovery
from ETEC challenge.
Introduction
Post-weaning diarrhea (PWD) is a serious threat to the economic success of the swine
industry, due both to losses as a result of mortality, as well as morbidity as evidenced by
reduced growth performance in surviving pigs. It is estimated that 50% of piglet
mortality due to diarrhea worldwide is attributable to the causative agent of PWD,
enterotoxigenic Escherichia coli (ETEC) (Gyles, et al., 2007). The ETEC most
commonly associated with PWD in pigs possess the F18 fimibrial type (Fairbrother et al.,
2005). As a result of the significant impact that F18 ETEC infections can have on pig
production, prophylactic antibiotics are frequently included in the diets of young pigs in
an attempt to stave off disease threats and for growth promotion. An estimated 78% of
large swine farms in the U.S. include antibiotics in the diets for young pigs (USDA,
2001). Despite the use of antibiotics in the diet, 48% of these farms reported disease
caused by E. coli infections (USDA, 2001). The lack of effective PWD prevention with
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the use of prophylactic antibiotics is not surprising, because of the frequency and
spectrum of antibiotic resistance seen among ETEC strains (Maynard et al., 2004; Lanz et
al., 2003; Choi et al., 2002). It is expected that antibiotic resistance will further increase
among these strains, based on the overall increase in resistance to antibiotics by ETEC
over the last 20 years (Maynard et al., 2004).
A potential alternative to conventional antibiotics that holds a great deal of promise are
colicins. Colicins are a class of bacteriocins produced by, and effective against, E. coli
and closely related bacteria (Fredericq, 1957). These proteins are particularly attractive
for use as an alternative to conventional antibiotics for the control of E. coli caused PWD
for several reasons. We have previously shown them to be effective against strains of
ETEC responsible for PWD in vitro (Stahl et al., 2004) and in vivo (Cutler, et. al., 2007).
Colicins are not related to any antibiotics that are currently being used in human
medicine. Also, colicins would not be absorbed intact by the animals, thereby
eliminating concerns over antibiotic residues in meat, and colicins could be effective at
low enough concentrations so as not to significantly alter the nutrient density of the diet.
The objectives of this study were to determine if dietary inclusion of Colicin E1 was
effective in preventing PWD in young pigs, if withdrawal of the colicin would have any
adverse effects on health of the animals, and if there were any growth promotive effects
of Colicin E1 feeding in non-challenged animals.
Materials and Methods
Colicin Production
Colicin E1 was produced and purified to homogeneity according to the method of Stahl,
et al. (2004). Briefly, a Colicin E1 producing strain of E. coli was grown in LB and
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colicin production was induced by the addition of Mitomycin C (EMD Biosciences, San
Diego, CA) to the media. The ColE1 was purified from the cell free supernatant by ion
exchange chromatography, first utilizing DEAE cellulose (Sigma-Aldrich, St. Louis,
MO) and then further purifying the protein utilizing Q sepharose (Amersham
Biosciences, Piscataway, NJ). The estimated purity of the Colicin E1, measured by
densitometry, used in this study was 90% (Patton, et al., 2007).
Animals
All of our protocols involving animals were approved by the Institutional Animal Care
and Use Committee of Iowa State University. The 28 barrows utilized for the challenge
portion of this study were determined to be susceptible to E. coli F18 based on a
restriction fragment length polymorphism test described by Frydendahl et al. (2003).
Briefly, genomic DNA was purified (DNeasy Kit, Qiagen, Valencia, CA) from pig tail
clippings and primers (forward -TTGGGAACCAGATGGGACAGTATG and reverse -
CCCGCCAAGGAGCGTGCCTGTCTA) were used to amplify a 162 bp section of the 1,
2 fucosyltransferase enzyme (FUT1M307 ECF18R gene) by PCR (Meijerink et al.,
2000). The 162 bp PCR product was then digested using Hha (New England Biolabs,
Ipswich, MD) and the polymorphism was determined by size comparison on a 3%
agarose gel. The remaining 20 animals were not tested for susceptibility to F18 ETEC as
these animals were used for feeding and growth comparision only. None of these pigs
showed any signs of diarrhea throughout the study. Pigs were weaned at 17 days of age
and allowed to adjust to solid food (TechStart 17-25, Kent Feeds, Muscatine, IA). At 21d
of age, the pigs were grouped by body weight.
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Diets
Pigs were fed with a 57% corn- 32% soybean meal starter diet consisting of 2.5% whey,
1% soy protein, and 4% corn oil. Colicin E1 was added to the diet at 20 mg/kg for the
treated groups, and no addition was included in the control groups. For the second two
week period, the whey and corn oil were removed for a 62.6% corn, 34% soybean meal
diet. All animals were fed the same diet for the second two week period.
ETEC challenge strains
Escherichia coli F18 strain 2144 (O147:NM) was obtained from the collection of Dr.
Nancy Cornick. Strain 2144 is a field isolate that produces the toxins STa and STb. The
challenge strain was grown overnight in LB at 37°C with shaking. It was then diluted to
an OD600 = 0.1 in fresh LB and allowed to grow to an OD600  1. The culture was then
centrifuged at 4,000 x g for 10 min at 4ºC in a Sorvall Super T21 centrifuge (Kendro,
Newton, CT), and the bacterial pellet was resuspended in 20% dextrose and 5% non-fat
dry milk. The challenge dose was determined by serial diluting and plating to provide
2x109 CFU/0.5 ml oral dose.
Challenge method
This study employed a seeder challenge model. Eight animals, genetically susceptible to
ETEC, were group housed and orally challenged at 3 weeks of age. After three days, two
animals of similar body weight and both showing profuse diarrhea were split one each
into the pen provided the control diet (N=9) and the Colicin E1 diet (N=10) for a natural
route of infection. Pigs that were used as seeders then became part of each feeding group
for a total of 11 pigs in the E1 fed group and 10 in the control diet group.
Fecal Cultures and PCR for the F18+ ETEC
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Polymerase chain reaction was performed to confirm shedding of the challenge strain
from fecal cultures. A 10µl fecal loop was inserted into the rectum of each pig daily for
14 days after challenge and then placed into 5ml sterile saline, then this sample was
serially diluted in saline and plated onto MacConkey’s agar. All recovered bacteria from
the countable dilution (less than 50, greater than 10) for each animal from each day were
boiled in sterile water for one minute for total DNA extraction, then diluted 1:10 for use
as template in the PCR reaction. Primers for F18 (forward: AGC TGA TAT AAC TTG
GAG CGG GCA, reverse: TTC TCT TGC TTA GCA GGG AGG CAT) were used to
amplify a 342 base pair fragment. Thermal cycling conditions were 95°C for 3 minutes,
30 seconds at 95°C then 65°C for 45 seconds for 30 cycles, then 72°C.
Analysis of gene expression
Isolation of RNA from the ileum was performed utilizing ileal mucosal scrapings and the
RNeasy Midi kit (Qiagen, Valencia, CA). Genomic DNA was eliminated from the
extracted total RNA using the DNA-free kit from Ambion (Austin, TX) according to the
manufacturer’s instructions. The RNA was reverse transcribed using Superscript III
(Invitrogen, Carlsbad, CA), and the RNA was removed from the resulting cDNA by
incubation with E. coli RNase H (Invitrogen) according to the manufacturer’s
instructions. Concentrations of cDNA were determined utilizing the Quant-it kit
(Invitrogen), and the cDNA samples were then stored at -80°C until analysis by real-time
PCR. Thermocycling conditions included 45 cycles of 30s of melting at 95ºC followed
by 30s of annealing and extension at 60ºC. Following amplification, all samples were
subjected to a melt curve analysis to insure that only a single product was formed.
Primer oligonucleotides (Table 1) were designed using “PrimerQuest” software available
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from Integrated DNA Technologies (Coralville, IA). All primer sets were validated to
amplify only the sequence of interest and to do so in a linear fashion over a 2 log range of
cDNA concentrations. The data from all samples was normalized to cDNA concentration
prior to statistical analysis.
Statistical analysis
Statistical analysis of the data was performed with Statistical Analysis Software version
9.1 (SAS, Cary, North Carolina) utilizing the GLM procedure. Treatment was considered
a fixed effect, and for growth parameters initial body weight was used as a covariate.
Results
ETEC Challenge
The ETEC strain 2144 oral challenge was successful in generating post-weaning diarrhea
in 70% of the seeder animals, including the two placed into the treatment pens. The
seeder animals had exhibited profuse, watery diarrhea before placement in the treatment
group pens and both continued to show clinical signs for at least ten days. Between days
five and seven after exposure to the seeder pigs nearly 80% of the control animals
exhibited diarrhea symtoms as compared to 30% in the E1 fed group (Figure 1). The
duration of the diarrhea in the control animals was an average of eight days. One animal
in the E1 fed challenged group showed diarrhea for nine days. PCR for the F18 fimbriae
indicated that all of the animals in both groups shed F18+ ETEC for at least two
consecutive days.
Growth Performance
Four of the 10 control animals lost weight in the first week after exposure to the seeder
animal (Table 2). One of the ColE1 fed animals lost weight. In the first week after the
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seeder pigs were introduced into the naive animals, 6 out of 9 control animals failed to
gain over 300g as compared to 2 of 10 in the ColE1 group. Four of the control animals
lost weight and two of the pigs lost more than 10% of their initial body weight. At week
one the challenged control group had significantly lower body weights compared to all of
the other groups (P < 0.05). At weeks two and three after exposure to the seeder pig, the
challenge control animals had lower (P< 0.05) body weights than the animals in the non-
challenged ColE1 and control fed groups. A trend existed for lower body weight in the
challenged control and ColE1 challenged animals at weeks 2, 3, and 4 (P < 0.1). There
were no significant differences in body weight between the nonchallenged animals at any
timepoint.
Gene Expression
Expression of TNF in the ileal mucosa at the end of the four week study was higher in
the control, challenged animals than any other group (Figure 2). COX-2 and
prostaglandin synthase were both higher in the challenged E1 animals than in the other
groups (Figure 3,4). There were no significant differences noted for gene expression of
epidermal growth factor or the epidermal growth factor receptor, glucose transporter 2, or
interleukin 10 (data not shown).
Discussion
We have previously shown that Colicin E1 in the post-weaning swine diet decreases the
duration and severity of PWD in piglets in a short duration, five day trial. That trial used
an oral challenge of ETEC strain 2144 in addition to another ETEC strain associated with
edema disease (Cutler, et al., 2007). One of the concerns when assessing dietary
interventions to reduce PWD is that the intervention merely delays the onset of disease
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until the often costly product is removed. To ensure that no deleterious effects would be
seen when Colicin E1 was removed from the diet after a two week period, a seeder pig
ETEC challenge model was utilized to continuously challenge animals. The ColE1 was
removed from the feed and the study was ended after an additional two weeks. There
was not a delayed onset of diarrhea in the challenged ColE1 animals two weeks after
exposure to a sick animal.
In addition, one of the major challenges of investigating PWD is the development of a
reliable, reproducible challenge model. The use of different challenge strains with
different fimbrial antigens and toxins expressed as well as varying resistance to
colonization among the study animals can result in enormous variation among ETEC
caused PWD studies (Madec, et al., 2000). We believe this aggressive challenge model
which utilized only genetically susceptible animals, serves to better evaluate the
practicality of a Colicin E1 inclusion in the diet. This seeder pig challenge model
resulted in a 78% incidence of diarrhea with an average duration of 8 days in the control
animals and 30% in the ColE1 fed animals with only one animal with an incidence of
diarrhea over two days (Figure 1). Because of the complex factors involved in
experimentally replicating PWD, comparing results from one study to the next, is a
hindrance to ETEC research and impairs the development of intervention strategies other
than changes in management practices (Madec, et al., 2000; Fairbrother, et al., 2005).
The use of genotyping for the F18 receptor in the pig intestine greatly improves the odds
of a successful challenge study compared to post mortem analysis of bacterial adhesion to
intestinal tissue (Frydendahl, et al., 2003; Madec, et al., 2000). Combining genetic
54
screening with the use of a natural infection model, may give more clinically relevant
results when testing interventions for PWD.
The gene expression data from this study gives an indication of longer term intestinal
effects after exposure to ETEC in animals that were actively infected with ETEC
challenge as opposed to those who were exposed but did not develop diarrhea. At four
weeks post-ETEC exposure and even after their body weight differences had recovered to
similar values to that of non-challenged animals and the E1 treated groups, the intestinal
development of the control animals may have been lagging behind the other groups.
Further, the impact of a prolonged inflammatory response, indicated by higher levels of
TNF in the challenged control animals indicates immune activation four weeks after
ETEC exposure (Figure 4). While higher levels of TNF inhibit intestinal repair, COX2
and prostaglandin synthase increase intestinal epithelial proliferation (Martin and
Wallace, 2006). COX 2 enzyme upregulation may also assist in intestinal immunity by
increasing Toll like receptor regulation thus making the intestine more responsive to
injury and infection (Stenson, 2007; Fukata, et al., 2006). The E1 challenged animals had
greater expression of COX2 and PGHS, when compared to all other groups which could
indicate a healthy immune environment in the intestine (Figure 3, 4). While the addition
of Colicin E1 to the diet of the non-challenged control animals had no effect on COX2
and PGHS, the reduced pathogenesis associated with the ETEC challenge noted in the
ETEC challenged ColE1 fed group (shorter duration of diarrhea, better body weight
gain). Since Col E1 kills the ETEC challenge strain used in this study, the addition of E1
to the diet most likely decreased the number of challenge bacteria able to cause disease as
noted by a reduction in ETEC recovered at day one post challenge (Cutler, et al., 2007).
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The pigs that were fed Colicin E1 had lower incidence of PWD and this may be practical
for use in the post-weaning swine diet without the environmental concerns of feeding
zinc oxide.
In conclusion, we have shown that the addition of 20 mg/kg Colicin E1 to the post-
weaning swine diet dramatically reduced the incidence and severity of ETEC caused
post-weaning diarrhea in pigs. The inclusion of Colicin E1 in the post weaning diet,
especially when used alongside dietary interventions currently in place for PWD could be
a practical solution for the reduction of ETEC caused PWD.
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Table 1. Primer sets for semi-quantitative real-time PCR analysis of intestinal gene
expression.
Gene name Primer sets
Epidermal Growth Factor (EGF) F: TGCCATAGACTGGATTGGCCGTAA
R: AGCAATTCCTCGTGGCTGAGAGAT
Epidermal Growth Factor receptor
(EGFR)
F: ACCGTGGAGAAGATCCCTTGGGAA
R: ATAAGACGGCTAAGGCATGGGTGT
Glucose transporter 2 (GLUT2) F: TTCATGTCGGTGGGACTTGTGCTA
R: AATTGCGGGTCCAGTTGCTGAATG
Interleukin 10 (IL10) F: AAGACGTAATGCCGAAGGCAGAGA
R: TGCTAAAGGCACTCTTCACCTCCT
Prostaglandin endoperoxide H Synthase
(PGHS)
F: ATCAGAAGCGAGGACCAGCTTTCA
R: ACTTGAGTGTCTTTGGCTGTCGGA
Cyclooxygenase 2 (COX-2) F: ATCAGAAGCGAGGACCAGCTTTCA
R: ACTTGAGTGTCTTTGGCTGTCGGA
Tumor necrosis factor  (TNF) F: GCCCACGTTGTAGCCAATGTCAAA
R: GTTGTCTTTCAGCTTCACGCCGTT
Table 2. Effect of dietary inclusion of Colicin E1 on growth performance of weaning pigs. Body weights are least squares
means.
Treatment
Week 1
Body wt
(kg)
SEM
Week 2
Body wt
(kg)
SEM
Week 3
Body wt
(kg)
SEM
Week 4
Body wt
(kg)
SEM
Week 5
Body wt
(kg)
SEM
Control 5.63 0.17 6.52b 0.26 8.6b 0.39 11.94ab 0.59 15.26 0.78
Challenged
Control 5.32 0.17 5.50
a 0.27 7.5a 0.63 10.32b 0.63 14.18 0.82
ColE1 5.40 0.17 6.77b 0.28 9.1b 0.63 12.38a 0.63 15.77 0.82
Challenged
ColE1 5.68 0.16 6.32
b 0.25 8.5ab 0.57 11.99ab 0.57 16.04 0.74
a,b value within a column not sharing a common superscript are different (P < 0.05)
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Figure 1. Percentage of animals exhibiting diarrhea over a ten day period after exposure
to a sick, seeder animal. * indicates difference (P < 0.05) between animals fed 20 mg/kg
Colicin E1 and those on a control diet with no addition. 18 days after exposure, no
animals exhibited diarrhea.
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Figure 2. Relative gene expression, normalized to cDNA concentration (25 ng/reaction),
of cycloxyengase 2 (COX-2) in intestinal mucosa of pigs fed 20mg/kg Colicin E1 or a
basal diet. Pigs that were challenged were exposed to a seeder pig showing clinical signs
of post-weaning diarrhea. a,b indicate P < 0.05. Tissue was collected 4 weeks after
exposure to the seeder animal.
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Figure 2. Relative gene expression of prostaglandin endoperoxide H synthase (PGHS)
normalized to cDNA concentration (25 ng/reaction), in intestinal mucosa of pigs fed
20mg/kg Colicin E1 or a basal diet. Pigs that were challenged were exposed to a seeder
pig showing clinical signs of post-weaning diarrhea. a,b indicate P < 0.05. Tissue was
collected 4 weeks after exposure to the seeder animal.
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Figure 3. Relative Gene Expression of tumor necrosis factor alpha (TNF) normalized
to cDNA concentration (25 ng/reaction), in intestinal mucosa of pigs fed 20mg/kg
Colicin E1 or a basal diet. Pigs that were challenged were exposed to a seeder pig
showing clinical signs of post-weaning diarrhea. a,b indicate P < 0.05. Tissue was
collected 4 weeks after exposure to the seeder animal.
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CHAPTER 3
EXPRESSION OF AN ACTIVE COLICIN E1 IN PICHIA
PASTORIS
Sara A. Cutler and Chad H. Stahl
A Manuscript for submission to Biotechnology Letters
Abstract
Colicins are a class of bacteriocins produced by, and effective against, Escherichia coli
and closely related species. Previous work in our lab has shown that Colicin E1 is highly
effective against the E. coli strains of concern for both animal health as well as human
food safety. Additionally, Colicin E1 has been shown effective against other food borne
pathogens such as Listeria monocytogenes. The objective of this study was to produce an
active Colicin E1 in a yeast expression system in order to reduce the costs associated with
native colicin production and purification.
Introduction
Colicin E1 has shown potential for use both as an alternative to conventional antibiotics
in animal feed as well as a novel intervention for the prevention of food borne disease in
humans (Trautner, et al., 2002; Patton, et al., 2007, Schamberger, et al., 2004). Colicin
E1 is naturally produced by stress induction via the SOS response in E. coli containing a
plasmid containing the genes for Colicin E1 (cae), its resistance protein, and a protein
required for its excretion from E. coli. In order to utilize this protein in food or feed
systems, considerable concentration and purification from native producers is necessary.
Other E. coli proteins have been successfully expressed in Pichia pastoris for use in
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animal agriculture (Ouyang, et al., 2003, Lee, et al., 2006, Stahl et al., 2000). The
objective of this study was to determine if an active Colicin E1 could be expressed in P.
pastoris.
Materials and Methods
A plasmid containing the Colicin E1 gene (cae) was isolated from E. coli obtained from
the National Collection of Type Cultures (Public Health Laboratory Service London,
England) (NC50132 and NC50145). The coding sequence of Colicin E1 was amplified
by PCR (forward: CACGTGTTATGGAAACCGCGGTAGCG and reverse:
GCGGCCGCTCAAATCCCTAACACCTC), ligated into pGEM-T (Promega Madison,
WI) and pGEMTcae was transformed into E. coli DH5 by electroporation (BTX ECM
630, 1.9kV, 200 ohms). Transformants were then grown for harvesting of this plasmid.
The Colicin E1 gene was excised from the pGEM-Tcae plasmid by digestion with Pml I
and Not I (New England Biolabs Ipswich, MA), ligated into the methanol inducible yeast
vector pPICZC (Invitrogen Carlsbad, CA) and transformed into E. coli DH5 for
maintenance of the plasmid and harvesting of the plasmid for transformation into yeast
(Plasmid Maxi kit Qiagen, Valencia, CA). The pPICZCcae plasmid was linearized by
digestion with Sac I (New England Biolabs), gel purified (Qiagen, QiaQuick Gel
Extraction kit), and then 1µg was added to 100µl of electrocompetent P. pastoris X33
and these cells were transformed with 1.5kV and 200 Ohms. Electrocompetent Pichia
pastoris strain X33 cells were prepared according to the method of Cereghino et.al,
(2005). One ml of 1M sorbitol was added to a 2mm cuvette after pulsing and this was
added to 1ml of yeast peptone dextrose broth (YPD). Tranformants were allowed to
64
recover while shaking at 30°C for one hour and then were plated on YPD/Sorbitol plates
with 100µg, 200µg, 500µg, and 1000µg/ml Zeocin (Invitrogen). Colonies were selected
from plates with the highest Zeocin concentration and screened for Colicin E1 production
by spot testing onto a lawn of DH5 and for killing activity in growing cultures of E.
coli.
Screening for Colicin E1 Activity
Yeast colonies selected for highest Zeocin resistance were grown in YPD for 48 hours.
The cultures were then induced for protein production with 1% methanol daily for two
days. Cultures were pelleted in microcentrifuge tubes at 10,000×g and the supernatant
was retained. The pellets were resuspended in 100 µl of 10mM Tris-HCL pH 7.6 with
approximately 100 µl of sterile glass beads (400-600 µm) and then sonicated (40 Amps,
20 Watts). This mixture was then centrifuged in a microcentrifuge tube at 16,000×g for
10 min. The cell extract was sterile filtered (0.22µm) and spotted onto a lawn of DH5
to determine Colicin E1 activity. The transformant showing the largest zone of inhibition
on the spot test was utilized in the expression characterization studies.
Expression Characterization
Fermentations with the selected pPICZCcae X33 yeast clone were performed in YPD
(yeast peptone dextrose) media until an OD600 of 15 was achieved, then methanol
induction (4%) was performed at 24 hour intervals.
To identify the expression pattern of the selected clones, the cell pellets were sonicated as
above and subjected to SDS-Page (4% stacking, 12% resolving, under denaturing
conditions) and Western blotting on a nitrocellulose membrane with a commercially
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available kit (Supersignal, Pierce). A polyclonal antibody was generated to the Colicin
E1 (Antibodies, Inc) in rabbits and was used as the primary antibody. The primary
antibody (1.1mg/ml) was diluted 1:15,000 in Superstart™ buffer with 0.01% Tween 20
and was applied to the membrane overnight on a rocker at 4°C. After rinsing the
membrane four times with TBS, the secondary horseradish peroxidase antibody was
diluted 1:5000 in TBS with 0.01% Tween 20 and allowed to incubated on a rocker for
one hour. The membrane was then washed four times with TBS, blotted dry, and
chemiluminescent substrate was applied. The blot was exposed using a charged coupled
device camera (Fluro-Chem 8800, Alpha Innotech Corporation, San Leandro, CA) for
two minutes and the resulting bands were analyzed with AlphaEaseFC software (Alpha
Innotech Corporation).
Expression of Colicin E1 mRNA
Real time PCR was utilized to show intracellular expression of Colicin E1 mRNA over a
time course. Yeast RNA was extracted using the RiboPure Yeast kit (Invitrogen,
Carlsbad, CA). RNA was quantified with the RiboGreen kit (Invitrogen) and cDNA was
generated with Superscript III and quantified with the OliGreen kit (Invitrogen). Twenty
five ng of cDNA was used as template in the reaction and real time PCR was performed
with SYBR Green using a BioRad iCycler. Primers were designed to the Colicin E1
sequence (forward, CCA TGC CCG TGA TGC AGA AAT GAA, reverse AAG GAC
GGT TCT GAA GCG GAT CAT) with the PrimerQuest software from IDT (Corallville,
IA).
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Results
Though the construct used for this recombinant P. pastoris contained the  factor that is
associated with extracellular expression of proteins, the Colicin E1 remained
intracellulary expressed under all culture conditions tested.
The growth curve for pPICZCcae X33 is shown in Figure 1. The Pichia was allowed to
grow until to an OD600 of 15 before methanol induction. After induction the yeast
doubled at 48 hours, then stayed at maximal concentration for the duration of the study.
Real time PCR quanitation of mRNA expression of Colicin E1 is also shown on Figure 1.
The day before induction there was no detectable measure of Colicin E1 mRNA, but 24
hours after induction with 4% methanol, a sharp increase in relative gene expression was
noted with a twenty fold reduction in message at 48 hours after induction, and a drop to
nearly undetectable levels in the last 3 days of the 5 day sampling period.
A Western blot showing protein production over the five day time course is Figure 2.
The largest band at 60Kd is at day two post-induction. As shown in figure two after
deglycosylation with EndoHF is performed the double band is reduced. The amino acid
sequence of Colicin E1 has two possible glycosylation sites at amino acids 26 and 104.
Discussion
After preliminary trials using other media, such as buffered methanol complex media
(BMMY), the best Colicin E1 production was accomplished using YPD media at 27°C
when the P pastoris reached an OD600 of 15. We also found that a larger amount of
methanol was more effective for protein induction than the recommended 1%. After
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preliminary trials, a 4% methanol addition once every 24 hours achieved the greatest
protein expression.
Though the alpha factor from Saccahromyces cerevisiae was included on the PIC vector
used in this expression construct, the P pastoris did not secrete the Colicin E1 into the
supernatant after methanol induction. Explanations for this may include toxicity to the
yeast cell by the colicin, that the colicin is being bound to the yeast cell membrane, or
that the glycosylation is changing the structure of the colicin so that it cannot be excreted.
Previous trials with the Colicin E1 attempted using a GAP vector with the alpha factor
and resultling in very few transformants, possibly indicating that the colicin is toxic to the
yeast cell upon excretion.
Intracellular expression allows for feeding the yeast directly to the pigs as a whole cell.
Yeast supplementation in the swine diet has been associated with greater feed conversion
and immunostimulatory properties (Li, et al., 2006; Eicher, et al., 2006). The use of a
recombinant proteins expressed in P pastoris in animal feed have been previously used
for nutritional, antigenic, or growth promotant applications (Stahl, et al., 2004; Fingerut,
et al., 2005; Ouyang, et al., 2003).
The addition of natively produced Colicin E1 to the swine diet has proven to be an
effective means to control post-weaning diarrhea (Cutler, et al., 2007), however
purification costs of feeding the natively produced E. coli protein make this method cost
prohibitive at this time. We have expressed a functional Colicin E1 protein in a yeast
system. This yeast may be directly fed to pigs, thus lessening the purification costs
associated with separating the Colicin E1 from the bacterial cell. Future studies will
elucidate the amount of yeast inclusion in the diet to prevent PWD.
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In addition to an application in the swine diet as a post-weaning diarrhea preventative,
Colicin E1 has recently been shown to be effective against Listeria monocytogenes as a
carcass spray (Patton, et al., 2007). The use of recombinant, instead of natively induced
Colicin E1 could make larger scale production of Colicin E1 possible.
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Figure 1. Growth of pPICZCcae X33 as measured by optical density over a five day
induction period is shown on the left axis. The first 4% methanol induction is noted by
an arrow, and the yeast was induced daily thereafter. Real time PCR was used to
measure mRNA expression of the Colicin E1 within the yeast cell and is shown on the
right axis.
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Figure 2. Western blot showing pPICZCcae X33 in the cell extract of the yeast cells
over a five day time course study. Molecular weight markers are shown on the right. On
the left side of the blot the samples were subjected to EndoHF enzyme treatment to
deglycosylate the protein and the Colicin E1 is shown as a single band ~60Kd. On the
right side of the blot the samples were denatured.
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GENERAL CONCLUSION
Post-weaning diarrhea remains a threat to swine production in the US despite the
use of antibiotic feed additives and other alternative therapies utilized in post-
weaning diets. With the potential for a reduction or ban on the use of
prophylactic antibiotics in the swine diet, alternatives are needed to retain the
economic solvency of swine production. Colicins are proteins produced by, and
effective against E. coli, including the enterotoxigenic Escherichia coli (ETEC)
responsible for post-weaning diarrhea. The addition of 16.5 of a mg/kg highly
purified Colicin E1 (ColE1) to a post-weaning ration reduced the duration and
severity of diarrhea caused by a combination of two F18+ ETEC strains over a
five day study. Semi-quantitative real time PCR of the ileum revealed lower
levels of mRNA expression for inflammatory cytokines IL-1 and TNF in the
16.5 mg/kg ColE1 fed group as compared to the control animals. These data,
taken together with a lower number of ETEC challenge bacteria recovered from
ColE1 fed animals 24 hours after oral challenge, suggests that the dietary ColE1
was able to reduce the numbers of ETEC able to colonize the ileum, thereby
rendering it unable to cause diarrhea.
In a longer duration study, utilizing a more natural seeder pig challenge model,
ColE1 was also efficacious. This study utilized a post weaning diet containing
thought to be protective against PWD such as spray dried plasma and whey
protein for the first two weeks. To this diet, 20 mg/kg ColE1 was added. As with
commercial practice, these ingredients were removed after two weeks and all
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animals were fed a corn/soy diet. Exposure to the seeder animal without dietary
ColE1 supplementation resulted in similar rates of PWD as those achieved by
direct oral challenge in the previous study. In this 4 week trial, the majority of the
diarrhea occurred between days 4 and 10 after exposure to the sick animal, with
over 80% of the non-treated animals exhibiting diarrhea during this time period.
Much lower rates of diarrhea were noted in the ColE1 fed group (18% during the
same period). Body weight gains were significantly higher in the ColE1 fed pigs
as a result, compared to those without the dietary addition at weeks 1 and 2. In a
group of pigs not exposed to ETEC challenge, no body weight differences were
noted when ColE1 was added to the diet. Semi quantitative real time PCR
analysis of ileum mucosa showed higher levels of TNF in the challenged, non-
treated animals than those with the ColE1 addition and both diets in the non-
challenged room 4 weeks after exposure to the seeder animal. Levels of COX-2
and PGHS, enzymes responsible for maintenance of immune function and barrier
function in the intestine, were higher in the ColE1 fed, challenged animals than
any other group.
Overall, the addition of the ColE1 purified from a Colicin E1 producing E. coli
culture reduced the incidence and severity of PWD in both an oral challenge
model and a seeder pig challenge model. The expense required to purify the
ColE1 used in this study makes it cost prohibitive for use as an additive in swine
feed at this time. For this reason, we have utilized recombinant yeast technology
to express the ColE1. This method requires no purification cost because
intracellular expression of the ColE1 enables the yeast cell to be directly fed to the
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pigs. Future studies will include testing of this yeast, the possible use of more
than one colicin to offer a broader spectrum against ETEC colonization, and
molecular manipulations to the colicin sequence to make it a more effective
antimicrobial for other applications, such as food safety.
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